- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/445 - Non-condensed piperidines, e.g. piperocaine
Patent holdings for IPC class A61K 31/445
Total number of patents in this class: 4519
10-year publication summary
|
353
|
312
|
321
|
318
|
277
|
331
|
324
|
300
|
228
|
79
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amicus Therapeutics, Inc. | 341 |
157 |
| Bristol-myers Squibb Company | 5080 |
45 |
| Merck Sharp & Dohme Corp. | 2247 |
45 |
| Janssen Pharmaceutica N.V. | 3839 |
45 |
| Takeda Pharmaceutical Company Limited | 2961 |
36 |
| The Regents of the University of California | 18943 |
35 |
| Theravance Biopharma R&D IP, LLC | 550 |
33 |
| Merck Sharp & Dohme LLC | 3689 |
32 |
| Novartis AG | 11238 |
31 |
| Boehringer Ingelheim International GmbH | 4629 |
30 |
| ChemoCentryx, Inc. | 400 |
29 |
| Suven Life Sciences Limited | 129 |
28 |
| Pacira Pharmaceuticals, Inc. | 85 |
27 |
| Eisai R&D Management Co., Ltd. | 1304 |
25 |
| H. Lundbeck A/S | 1252 |
25 |
| Incyte Corporation | 918 |
24 |
| The Trustees of the University of Pennsylvania | 4122 |
23 |
| Heron Therapeutics, Inc. | 156 |
23 |
| F. Hoffmann-La Roche AG | 7958 |
22 |
| Merck & Co., Inc. | 607 |
21 |
| Other owners | 3783 |